STARLIX Side Effects

7013333-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Atrioventricular Block First Degree, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Cholesterol Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Sodium Decreased
on Sep 15, 2010 Male patient from GERMANY , weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus, peripheral arterial occlusive disease, hypertension and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block first degree, blood alkaline phosphatase increased, blood bilirubin increased, blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased. Starlix dosage: 1 Df, Qd. During the same period patient was treated with ISCOVER (Unk) (View Iscover Review and Iscover Label ), COVERSUM (1 Df, Per Day) (View Coversum Review and Coversum Label ), CONCOR COR (5 Mg, Per Day) (View Concor Cor Review and Concor Cor Label ). Patient was hospitalized.

6909293-X | Balance Disorder, Cerebrovascular Accident, Fall, Pelvic Fracture
Patient was taking Starlix (View Usage). Patient had the following side effects: balance disorder, cerebrovascular accident, fall (What is fall?), pelvic fracture on Jul 26, 2010 from BRAZIL Additional patient health information: Female patient , 85 years of age, weighting 125.7 lb, was diagnosed with diabetes mellitus, hypertension, urinary retention, coagulopathy, cystitis and. Starlix dosage: 1/2 Tab Daily. During the same period patient was treated with MODURETIC 5 50 (1 Tab/day) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), MAREVAN (1 Tab/day (5 Mg)) (View Marevan Review and Marevan Label ), RETEMIC UD (1 Tab/day) (View Retemic Ud Review and Retemic Ud Label ). Patient was hospitalized.

6769815-9 | Abdominal Pain, Cholelithiasis, Diarrhoea
Adverse event was reported on Jun 03, 2010 by a Female patient taking Starlix (View Usage) (Dosage: 120 Mg, Tid) was diagnosed with diabetes mellitus and. Location: CHINA , 75 years of age, After Starlix was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cholelithiasis, diarrhoea.

6695402-7 | Dysgeusia, Eructation, Fear, Gingivitis, Tongue Disorder
on Apr 22, 2010 Female patient from UNITED STATES , 66 years of age, weighting 215.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, eructation, fear, gingivitis, tongue disorder. Starlix dosage: 120 Mg. Tablets 3x1day Oral.


6581140-8 | Psoriasis
on Feb 12, 2010 Male patient from AUSTRALIA , weighting 190.0 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hot flush, prophylaxis and was treated with Starlix (View Usage). Patient had the following side effects: psoriasis. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), OGEN (Unk) (View Ogen Review and Ogen Label ), CATAPRES (View Catapres Review and Catapres Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ). Patient was hospitalized.

6581138-X | Acute Myeloid Leukaemia, Anaemia, Concomitant Disease Progression, Multi-organ Failure, Neutropenic Sepsis, Thrombocytopenia
Patient was taking Starlix (View Usage). After Starlix was administered, patient had the following side effects: acute myeloid leukaemia, anaemia, concomitant disease progression, multi-organ failure, neutropenic sepsis, thrombocytopenia on Feb 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 241.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 2) (View Diovan T30230+caps Review and Diovan T30230+caps Label ). Patient was hospitalized.

6579071-2 | Convulsion, Fall, Hypoglycaemia
Adverse event was reported on Feb 12, 2010 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension, hypercholesterolaemia and. Location: UNITED KINGDOM , weighting 137.8 lb, Patient experienced the following unwanted or unexpected effects: convulsion, fall (What is fall?), hypoglycaemia. During the same period patient was treated with VALSARTAN (Level 1) (View Valsartan Review and Valsartan Label ), ADIZEM XL (300 Mg, Qd) (View Adizem-xl Review and Adizem-xl Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6579070-0 | Abdominal Pain, Arrhythmia, Disease Progression, Dyspnoea, Nausea, Ventricular Fibrillation, Ventricular Tachycardia
on Feb 12, 2010 Female patient from BRAZIL , weighting 154.3 lb, was diagnosed with glucose tolerance impaired, hypertension, dyslipidaemia and was treated with Starlix (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arrhythmia (What is arrhythmia?), disease progression, dyspnoea, nausea (What is nausea?), ventricular fibrillation, ventricular tachycardia. Starlix dosage: Level 1. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ACETYLSALICYLATE (View Acetylsalicylate Review and Acetylsalicylate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6579067-0 | Bone Marrow Disorder, Chest Wall Mass, Erythema, Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv, Lymphadenopathy, Lymphocyte Count Increased, Mass Excision, Neoplasm Malignant, Neoplasm Progression
on Feb 12, 2010 Male patient from UNITED KINGDOM , weighting 228.6 lb, was diagnosed with glucose tolerance impaired and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: bone marrow disorder, chest wall mass, erythema, follicle centre lymphoma, follicular grade i, ii, iii stage iv, lymphadenopathy, lymphocyte count increased, mass excision, neoplasm malignant, neoplasm progression. Starlix dosage: Level 1. During the same period patient was treated with VALSARTAN (Level 1) (View Valsartan Review and Valsartan Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6579064-5 | Acute Myeloid Leukaemia, Bone Marrow Failure, Cardio-respiratory Arrest, Disease Progression, Febrile Neutropenia, Leukopenia, Myelodysplastic Syndrome
Patient was taking Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, bone marrow failure, cardio-respiratory arrest, disease progression, febrile neutropenia, leukopenia, myelodysplastic syndrome on Feb 12, 2010 from TURKEY Additional patient health information: Female patient , weighting 163.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Starlix dosage: Level 2. During the same period patient was treated with DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6578523-9 | Abscess Drainage, Anastomotic Leak, Chills, Colectomy, Colon Cancer Stage Ii, Disease Progression, Gastric Ph Decreased, Haematoma Evacuation, Haematoma Infection
Adverse event was reported on Feb 11, 2010 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Location: UNITED STATES , weighting 233.7 lb, Patient had the following side effects: abscess drainage, anastomotic leak, chills, colectomy, colon cancer stage ii, disease progression, gastric ph decreased, haematoma evacuation, haematoma infection. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ). Patient was hospitalized.

6578522-7 | Atrial Flutter, Cardiac Ablation, Cardiac Murmur, Disease Progression, Dizziness, Dyspnoea, Feeling Abnormal, Fibrin D Dimer Increased, Heart Rate Increased
on Feb 11, 2010 Female patient from UNITED STATES , weighting 270.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension, prophylaxis and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: atrial flutter, cardiac ablation, cardiac murmur, disease progression, dizziness (What is dizziness?), dyspnoea, feeling abnormal, fibrin d dimer increased, heart rate increased. Starlix dosage: Level 1. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VASOTEC (View Vasotec Review and Vasotec Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6577710-3 | Chest Pain, Fall, Headache, Hypertensive Crisis, Mobility Decreased, Weight Increased
on Feb 11, 2010 Male patient from RUSSIAN FEDERATION , weighting 227.1 lb, was diagnosed with glucose tolerance impaired, essential hypertension and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), fall (What is fall?), headache (What is headache?), hypertensive crisis, mobility decreased, weight increased. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN (Level 1) (View Diovan Review and Diovan Label ), NICARDIA (40 Mg) (View Nicardia Review and Nicardia Label ). Patient was hospitalized.

6577709-7 | Cholangitis, Jaundice, Pancreatitis, Pyrexia, Splenectomy
Patient was taking Starlix (View Usage). Patient had the following side effects: cholangitis, jaundice (What is jaundice?), pancreatitis, pyrexia, splenectomy on Feb 11, 2010 from FRANCE Additional patient health information: Male patient , weighting 192.2 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Starlix dosage: 30 Mg, Level 1. During the same period patient was treated with ASPERGIC (View Aspergic Review and Aspergic Label ), QUESTRAN (View Questran Review and Questran Label ). Patient was hospitalized.

6577707-3 | Abdominal Pain Upper, Gastritis, Gastritis Erosive, Intestinal Operation, Laparotomy, Non-hodgkin's Lymphoma Stage Iv, Shock, Small Intestinal Haemorrhage, Vomiting
Adverse event was reported on Feb 11, 2010 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Location: CHINA , weighting 163.1 lb, After Starlix was administered, patient had the following side effects: abdominal pain upper, gastritis, gastritis erosive, intestinal operation, laparotomy, non-hodgkin's lymphoma stage iv, shock, small intestinal haemorrhage, vomiting. During the same period patient was treated with VALSARTAN (Level 1) (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6577706-1 | Abdominal Pain, Cholecystectomy, Cholelithiasis, Pancreatitis, Vomiting
on Feb 11, 2010 Male patient from UNITED KINGDOM , weighting 175.5 lb, was diagnosed with glucose tolerance impaired, hypertension, dyspepsia and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cholecystectomy, cholelithiasis, pancreatitis, vomiting. Starlix dosage: Level 2. During the same period patient was treated with CO TENIDONE (View Co-tenidone Review and Co-tenidone Label ), RANIDINE (150 Mg, Unk) (View Ranidine Review and Ranidine Label ). Patient was hospitalized.

6577705-X | Syncope
on Feb 11, 2010 Male patient from ITALY , weighting 205.0 lb, was diagnosed with glucose tolerance impaired and was treated with Starlix (View Usage). Patient had the following side effects: syncope. Starlix dosage: Level 1. Patient was hospitalized.

6577701-2 | Anaemia, Angiodysplasia, Arteriovenous Malformation, Asthenia, Chest Pain, Colonic Polyp, Concomitant Disease Progression, Diverticulum Intestinal, Epistaxis
Patient was taking Starlix (View Usage). After Starlix was administered, patient had the following side effects: anaemia, angiodysplasia, arteriovenous malformation (What is arteriovenous malformation?), asthenia, chest pain (What is chest pain?), colonic polyp (What is colonic polyp?), concomitant disease progression, diverticulum intestinal, epistaxis on Feb 11, 2010 from BRAZIL Additional patient health information: Male patient , weighting 139.6 lb, was diagnosed with type 2 diabetes mellitus, cardiovascular disorder, hypertension and. Starlix dosage: Level 1. During the same period patient was treated with VALSARTAN (Level 1) (View Valsartan Review and Valsartan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6577693-6 | Abdominal Pain, Pancreatitis Acute, Vomiting
Adverse event was reported on Feb 10, 2010 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired, cardiac valve disease, gastrooesophageal reflux disease, atrial fibrillation (What is atrial fibrillation?), prophylaxis, osteoarthritis (What is osteoarthritis?) and. Location: UNITED KINGDOM , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), pancreatitis acute, vomiting. During the same period patient was treated with FRUSEMIDE (View Frusemide Review and Frusemide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ). Patient was hospitalized.

6577206-9 | Chest Pain, Dyspnoea, Hypertension, Tachycardia
on Feb 10, 2010 Female patient from UNITED STATES , weighting 181.2 lb, was diagnosed with glucose tolerance impaired, hypertension and was treated with Starlix (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, hypertension, tachycardia. Starlix dosage: 60 Mg, Unk. During the same period patient was treated with DIOVAN T30230+CAPS (Level1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), CLONIDINE (.1 Mg, Bid) (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6516970-1 | Arrhythmia, Atrial Fibrillation, Cardiac Pacemaker Insertion, Chest Discomfort, Disease Progression
on Dec 21, 2009 Male patient from UNITED STATES , weighting 212.5 lb, was diagnosed with cardiovascular disorder and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), cardiac pacemaker insertion, chest discomfort, disease progression. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6509988-6 | Basal Cell Carcinoma, Dermatitis, Eczema, Pruritus, Secretion Discharge, Skin Exfoliation, Skin Neoplasm Excision
Patient was taking Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: basal cell carcinoma, dermatitis, eczema (What is eczema?), pruritus, secretion discharge, skin exfoliation, skin neoplasm excision on Dec 21, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , weighting 149.3 lb, was diagnosed with cardiovascular disorder and. Starlix dosage: Level 1. Patient was hospitalized.

6508130-5 | Acute Myocardial Infarction, Chest Pain, Coronary Artery Disease, Coronary Artery Stenosis, Disease Progression, Surgery
Adverse event was reported on Dec 18, 2009 by a Male patient taking Starlix (View Usage) (Dosage: ) was diagnosed with cardiovascular disorder and. Location: CHILE , weighting 238.1 lb, Patient had the following side effects: acute myocardial infarction, chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?), coronary artery stenosis, disease progression, surgery (What is surgery?). Patient was hospitalized.

6507336-9 | Atelectasis, Bladder Catheterisation, Breath Sounds Abnormal, Decreased Appetite, Dizziness, Increased Bronchial Secretion, Lung Consolidation, Lymphadenopathy, Malaise
on Dec 18, 2009 Male patient from SINGAPORE , weighting 136.7 lb, was diagnosed with cardiovascular disorder and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: atelectasis, bladder catheterisation, breath sounds abnormal, decreased appetite, dizziness (What is dizziness?), increased bronchial secretion, lung consolidation, lymphadenopathy, malaise. Starlix dosage: Level 1. During the same period patient was treated with OXYBUTYNIN CHLORIDE (2.5 Mg, Tid) (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), ALFUZOSIN HCL (Unk) (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6507333-3 | C-reactive Protein Increased, Pneumonia, Procalcitonin Increased, White Blood Cell Count Increased
on Dec 18, 2009 Male patient from SOUTH AFRICA , weighting 191.8 lb, was diagnosed with cardiovascular disorder and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, pneumonia (What is pneumonia?), procalcitonin increased, white blood cell count increased. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ). Patient was hospitalized.

6507258-3 | Cardiac Failure Congestive, Dyspnoea, Left Ventricular Failure, Lower Respiratory Tract Infection
Patient was taking Starlix (View Usage). Patient had the following side effects: cardiac failure congestive, dyspnoea, left ventricular failure, lower respiratory tract infection on Dec 15, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 157.2 lb, was diagnosed with cardiovascular disorder, coronary artery disease (What is coronary artery disease?), angina pectoris, asthma (What is asthma?) and. Starlix dosage: Level 1. During the same period patient was treated with MONOMAX (View Monomax Review and Monomax Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6506252-6 | Cervical Vertebral Fracture, Contusion, Fall, Hypotension, Loss Of Consciousness, Skin Laceration, Syncope
Adverse event was reported on Dec 18, 2009 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder, hypertension and. Location: UNITED STATES , weighting 227.1 lb, After Starlix was administered, patient had the following side effects: cervical vertebral fracture, contusion, fall (What is fall?), hypotension, loss of consciousness, skin laceration, syncope. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), FELODIPINE (10 Mg A.m) (View Felodipine Review and Felodipine Label ). Patient was hospitalized.

6504205-5 | Atrial Fibrillation, Bradycardia, Cardiac Arrest, Cardiac Pacemaker Insertion, Hyperkalaemia, Renal Impairment, Syncope
on Dec 17, 2009 Male patient from AUSTRIA , weighting 238.1 lb, was diagnosed with cardiovascular disorder, renal impairment, hypertension, cardiac failure, hyperlipidaemia and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, cardiac arrest (What is cardiac arrest?), cardiac pacemaker insertion, hyperkalaemia, renal impairment, syncope. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), ALDACTONE (50 Mg X 2 Per Week) (View Aldactone Review and Aldactone Label ), ACEMIN (5 Mg, Qd) (View Acemin Review and Acemin Label ), LASIX (View Lasix Review and Lasix Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6504201-8 | Abdominal Pain Upper, Decreased Appetite, Hyperhidrosis, Malaise, Urine Output Decreased, Vomiting
on Dec 16, 2009 Female patient from UNITED KINGDOM , weighting 147.3 lb, was diagnosed with cardiovascular disorder and was treated with Starlix (View Usage). Patient had the following side effects: abdominal pain upper, decreased appetite, hyperhidrosis, malaise, urine output decreased, vomiting. Starlix dosage: Level 1. During the same period patient was treated with DIOVAN T30230+CAPS (Level 1) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6503116-9 | Bronchitis, Hyponatraemia, Nausea, Renal Failure
Patient was taking Starlix (View Usage). After Starlix was administered, patient had the following side effects: bronchitis (What is bronchitis?), hyponatraemia, nausea (What is nausea?), renal failure on Dec 15, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 229.7 lb, was diagnosed with cardiovascular disorder and. Starlix dosage: Unk. During the same period patient was treated with DIOVAN T30230+CAPS (Unk) (View Diovan T30230+caps Review and Diovan T30230+caps Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), TRICOR (View Tricor Review and Tricor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6491372-5 | Bone Marrow Disorder, Chest Wall Mass, Erythema, Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv, Lymphadenopathy, Lymphocyte Count Increased, Mass Excision, Neoplasm Malignant, Neoplasm Progression
Adverse event was reported on Dec 08, 2009 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired and. Location: UNITED KINGDOM , weighting 228.6 lb, Patient experienced the following unwanted or unexpected effects: bone marrow disorder, chest wall mass, erythema, follicle centre lymphoma, follicular grade i, ii, iii stage iv, lymphadenopathy, lymphocyte count increased, mass excision, neoplasm malignant, neoplasm progression. During the same period patient was treated with VALSARTAN (Level 1) (View Valsartan Review and Valsartan Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6483623-8 | Acute Myeloid Leukaemia, Anaemia, Concomitant Disease Progression, Multi-organ Failure, Neutropenic Sepsis, Thrombocytopenia
on Dec 04, 2009 Male patient from UNITED KINGDOM , weighting 241.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Starlix (View Usage). Patient had the following side effects: acute myeloid leukaemia, anaemia, concomitant disease progression, multi-organ failure, neutropenic sepsis, thrombocytopenia. Starlix dosage: Level 1. Patient was hospitalized.

6444835-2 | Acute Myeloid Leukaemia, Anaemia, Concomitant Disease Progression, Multi-organ Failure, Thrombocytopenia
on Nov 13, 2009 Male patient from UNITED KINGDOM , weighting 241.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: acute myeloid leukaemia, anaemia, concomitant disease progression, multi-organ failure, thrombocytopenia. Starlix dosage: Level 1. Patient was hospitalized.

6440655-3 | Acute Myeloid Leukaemia, Anaemia, Concomitant Disease Progression, Multi-organ Failure, Thrombocytopenia
Patient was taking Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, anaemia, concomitant disease progression, multi-organ failure, thrombocytopenia on Nov 10, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 241.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Starlix dosage: Level 1. Patient was hospitalized.

6422212-8 | Acute Myeloid Leukaemia, Anaemia, Multi-organ Failure, Thrombocytopenia
Adverse event was reported on Oct 29, 2009 by a Male patient taking Starlix (View Usage) (Dosage: Level 1) was diagnosed with glucose tolerance impaired, cardiovascular disorder and. Location: UNITED KINGDOM , weighting 241.8 lb, Patient had the following side effects: acute myeloid leukaemia, anaemia, multi-organ failure, thrombocytopenia. Patient was hospitalized.

6412887-1 | Acute Myeloid Leukaemia, Multi-organ Failure
on Oct 19, 2009 Male patient from UNITED KINGDOM , weighting 241.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: acute myeloid leukaemia, multi-organ failure. Starlix dosage: Level 1. Patient was hospitalized.

6392522-1 | Abdominal Pain, Arrhythmia, Disease Progression, Dyspnoea, Nausea, Ventricular Fibrillation, Ventricular Tachycardia
on Sep 29, 2009 Female patient from BRAZIL , weighting 154.3 lb, was diagnosed with glucose tolerance impaired, hypertension, dyslipidaemia and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), arrhythmia (What is arrhythmia?), disease progression, dyspnoea, nausea (What is nausea?), ventricular fibrillation, ventricular tachycardia. Starlix dosage: 60 Mg, Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ACETYLSALICYLATE (View Acetylsalicylate Review and Acetylsalicylate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6335402-X | Blood Glucose Increased, Diabetes Mellitus, Disease Progression, Weight Increased
Patient was taking Starlix (View Usage). Patient had the following side effects: blood glucose increased, diabetes mellitus, disease progression, weight increased on Aug 24, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 200.6 lb, was diagnosed with diabetes mellitus and. Starlix dosage: Unk. During the same period patient was treated with LANTUS (70 U, Unk) (View Lantus Review and Lantus Label ).

6192263-X | Blood Glucose Increased, Diabetes Mellitus, Disease Progression, Weight Increased
Adverse event was reported on May 07, 2009 by a Female patient taking Starlix (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 200.6 lb, After Starlix was administered, patient had the following side effects: blood glucose increased, diabetes mellitus, disease progression, weight increased. During the same period patient was treated with INSULIN GLARGINE (70 U, Unk) (View Insulin Glargine Review and Insulin Glargine Label ).

6174096-3 | Eye Haemorrhage
on Apr 21, 2009 Female patient from UNITED STATES , 78 years of age, was diagnosed with hypercholesterolaemia, hypothyroidism, hypertension, stress (What is stress?), heart rate irregular, osteoporosis (What is osteoporosis?) and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: eye haemorrhage. Starlix dosage: 60 Mg, Qd. During the same period patient was treated with LIPITOR (20 Mg, Qd) (View Lipitor Review and Lipitor Label ), LEVOTHYROXINE SODIUM (0.88 Mg, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TIAZAC (240 Mg, Qd) (View Tiazac Review and Tiazac Label ), VALIUM (5 Mg, Prn) (View Valium Review and Valium Label ), LANOXIN (0.25 Mg, Qd) (View Lanoxin Review and Lanoxin Label ), BONIVA (150 Mg, Qmo) (View Boniva Review and Boniva Label ), ENALAPRIL (20 Mg, Qd) (View Enalapril Review and Enalapril Label ).

6133398-7 | Eye Haemorrhage
on Mar 18, 2009 Female patient from UNITED STATES , 78 years of age, was treated with Starlix (View Usage). Patient had the following side effects: eye haemorrhage. Starlix dosage: 60 Mg, Qd.

6082669-1 | Balance Disorder, Cerebrovascular Accident
Patient was taking Starlix (View Usage). After Starlix was administered, patient had the following side effects: balance disorder, cerebrovascular accident on Feb 09, 2009 from BRAZIL Additional patient health information: Female patient , 85 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus, hypertension, urinary retention, coagulopathy, cystitis and. Starlix dosage: 1/2 Tab Daily. During the same period patient was treated with MODURETIC 5 50 (1 Tab/day) (View Moduretic 5-50 Review and Moduretic 5-50 Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ), MAREVAN (1 Tab/day) (View Marevan Review and Marevan Label ), RETEMIC UD (1 Tab/day) (View Retemic Ud Review and Retemic Ud Label ). Patient was hospitalized.

6078185-3 | Anaemia, Hyperglycaemia, Simple Partial Seizures
Adverse event was reported on Feb 05, 2009 by a Male patient taking Starlix (View Usage) (Dosage: 180 Mg/day (60 Mg Every 8 Hours)) was diagnosed with diabetes mellitus and. Location: GUATEMALA , 60 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, hyperglycaemia, simple partial seizures. During the same period patient was treated with METFORMIN HCL (1700 Mg/day (850 Mg Twice Daily)) (View Metformin Hcl Review and Metformin Hcl Label ), GABAPENTIN (1200 Mg/day ( 400 Mg Thrice Daily)) (View Gabapentin Review and Gabapentin Label ), IRBESARTAN (300 Mg/day (150 Mg Every 12 Hours)) (View Irbesartan Review and Irbesartan Label ), HYPERLIPEN (200 Mg/day (100 Mg Every 12 Hours)) (View Hyperlipen Review and Hyperlipen Label ), LANSOPRAZOLE (30mg/day) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5928206-0 | Arrhythmia
on Oct 15, 2008 Male patient from CHINA , 41 years of age, was treated with Starlix (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Starlix dosage: 60 Mg, Tid. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ).

5919324-1 | Myocardial Infarction, Surgery
on Oct 06, 2008 Female patient from BRAZIL , 76 years of age, was diagnosed with diabetes mellitus and was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: myocardial infarction, surgery (What is surgery?). Starlix dosage: 120 Mg/day ; 1 Tablet/day. Patient was hospitalized.

5886662-0 | Neuropathy Peripheral, Nodule On Extremity, Pain In Extremity, Skin Discolouration
Patient was taking Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral, nodule on extremity, pain in extremity, skin discolouration on Sep 10, 2008 from BRAZIL Additional patient health information: Male patient , 58 years of age, was diagnosed with hyperglycaemia, diabetes mellitus and. Starlix dosage: 1.5 Tablet Per Day. During the same period patient was treated with METFORMIN HCL (3 Tablets Per Day) (View Metformin Hcl Review and Metformin Hcl Label ).

5778000-9 | Abdominal Pain Upper
Adverse event was reported on Jun 18, 2008 by a Female patient taking Starlix (View Usage) (Dosage: 120 Mg Before Meals Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 199.0 lb, Patient had the following side effects: abdominal pain upper. During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ).

5742218-1 | Bone Pain, Muscular Weakness, Urinary Tract Infection
on May 09, 2008 Female patient from UNITED STATES , 92 years of age, weighting 171.0 lb, was treated with Starlix (View Usage). After Starlix was administered, patient had the following side effects: bone pain, muscular weakness, urinary tract infection (What is urinary tract infection?). Starlix dosage: . During the same period patient was treated with ENBREL (Unk, Qw) (View Enbrel Review and Enbrel Label ), PREDNISONE (5 Mg, Qd) (View Prednisone Review and Prednisone Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), VICODIN (View Vicodin Review and Vicodin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NEXIUM (View Nexium Review and Nexium Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5700256-9 | Urticaria
on Apr 08, 2008 Male patient from UNITED STATES , 75 years of age, weighting 274.0 lb, was diagnosed with diabetes mellitus and was treated with Starlix (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Starlix dosage: One 3 Times A Day Po (duration: About A Year).

5615474-8 | Diabetes Mellitus Inadequate Control
Patient was taking Starlix (View Usage). Patient had the following side effects: diabetes mellitus inadequate control on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with blood glucose and. Starlix dosage: 1 Tablet Po Four Times A Day. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ).